Yu-Ling YANG

Biohybrid M13 phage backpacks for active blood–brain barrier traversal and precision central nervous system leukemia treatment

Abstract Central nervous system (CNS) leukemia remains a major clinical challenge in acute lymphoblastic leukemia, largely due to the restrictive nature of the blood–brain barrier (BBB), which severely limits therapeutic delivery and contributes to high relapse rates and poor pro...